Crescent Biopharma, Inc. (CBIO) Operating income 2016–2025
Crescent Biopharma, Inc. (CBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$152.6MFY2025 · since FY2016: -$31.9M → -$152.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$152.6M | -281.2% |
| FY2024 | -$40.0M | -1.9% |
| FY2023 | -$39.3M | +17.1% |
| FY2022 | -$47.4M | +25.3% |
| FY2021 | -$63.4M | -23.2% |
| FY2020 | -$51.5M | +16.1% |
| FY2019 | -$61.4M | -19.2% |
| FY2018 | -$51.5M | -51.8% |
| FY2017 | -$33.9M | -6.3% |
| FY2016 | -$31.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice